Cell and Gene Therapy Clinical Trials Market

The cell and gene therapy clinical trials market encompasses the structured testing of investigational therapies that use genetically modified cells or gene-editing techniques on humans. Key customers are biotech firms, academic institutions, and contract research organizations (CROs) developing treatments for patients with chronic and rare conditions. The market's growth is primarily driven by the rising demand for curative treatments, a strong push for precision medicine, increased R&D investment, and supportive regulatory pathways that accelerate development timelines.